A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema

Methods Patients (n = 30) who had been diagnosed with ACE-inhibitor-induced angioedema of the upper aerodigestive tract were randomly assigned to treatment with 30 mg of subcutaneous icatibant or to the current off-label standard therapy consisting of intravenous prednisolone (500 mg) plus clemastin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB243-AB243
Main Authors: Strassen, Ulrich, Greve, Jens, Stelter, Klaus, Havel, Miriam, Rotter, Nicole, Veit, Johannes, Schossow, Beate, Hapfelmeier, Alexander, Kehl, Victoria, Kojda, Georg, Hoffmann, Thomas K, Bas, Murat, MD
Format: Article
Language:English
Subjects:
Allergy and Immunology
Edema
Heart attacks
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods Patients (n = 30) who had been diagnosed with ACE-inhibitor-induced angioedema of the upper aerodigestive tract were randomly assigned to treatment with 30 mg of subcutaneous icatibant or to the current off-label standard therapy consisting of intravenous prednisolone (500 mg) plus clemastine (2 mg).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2015.12.979